MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/0115672050243131230925034334

Медицинская библиотека · Current Alzheimer research · 2023

Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum.

Atay Lutfiye Ozlem, Saka Esen, Akdemir Umit Ozgur, Yetim Ezgi, Balcı Erdem, Arsava Ethem Murat, Topcuoglu Mehmet Akif

СтатьяПеревод пока не подготовлен

Аннотация

AIMS: We aimed to investigate the interaction between β -amyloid (Aβ) accumulation and cerebral glucose metabolism, cerebral perfusion, and cerebral structural changes in the Alzheimer's disease (AD) clinical continuum.

BACKGROUND

Utility of positron emission tomography (PET) / magnetic resonance imaging (MRI) hybrid imaging for diagnostic categorization of the AD clinical continuum including subjective cognitive decline (SCD), amnestic mild cognitive impairment (aMCI) and Alzheimer's disease dementia (ADD) has not been fully crystallized.

OBJECTIVE

To evaluate the interaction between Aβ accumulation and cerebral glucose metabolism, cerebral perfusion, and cerebral structural changes such as cortex thickness or cerebral white matter disease burden and to detect the discriminative yields of these imaging modalities in the AD clinical continuum.

METHODS

Fifty patients (20 women and 30 men; median age: 64 years) with clinical SCD (n=11), aMCI (n=17) and ADD (n=22) underwent PET/MRI with [18F]-fluoro-D-glucose (FDG) and [18F]- Flutemetamol in addition to cerebral blood flow (CBF) and quantitative structural imaging along with detailed cognitive assessment.

RESULTS

High Aβ deposition (increased temporal [18F]-Flutemetamol standardized uptake value ratio (SUVr) and centiloid score), low glucose metabolism (decreased temporal lobe and posterior cingulate [18F]-FDG SUVr), low parietal CBF and right hemispheric cortical thickness were independent predictors of low cognitive test performance.

CONCLUSION

Integrated use of structural, metabolic, molecular (Aβ) and perfusion (CBF) parameters contribute to the discrimination of SCD, aMCI, and ADD.

Для цитирования: Atay Lutfiye Ozlem, Saka Esen, Akdemir Umit Ozgur, Yetim Ezgi, Balcı Erdem, Arsava Ethem Murat, Topcuoglu Mehmet Akif. Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum.. Current Alzheimer research. 2023. DOI: 10.2174/0115672050243131230925034334.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.